相关实验视频

Updated: Jan 13, 2026

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line
08:07

Differentiation of the SH-SY5Y Human Neuroblastoma Cell Line

Published on: February 17, 2016

76.7K

CDK4/6抑制剂在诱导神经母细胞瘤细胞分化方面表现出一个类效应

Kirsty M Ferguson1, Fiona M Y Abou Grealy1, Anna Philpott1,2

  • 1Jeffrey Cheah Biomedical Centre, Cambridge Stem Cell Institute, Cambridge, CB2 0AW, UK.

Wellcome open research
|October 28, 2025
PubMed
概括

循环素依赖激酶 (CDK) 4/6 抑制剂,包括palbociclib,abemaciclib和ribociclib,增强网红酸诱导的神经母细胞瘤细胞分化. 这一发现支持基于CDK抑制剂的分化疗法用于神经母细胞瘤.

关键词:
在CDK4/6中使用.一个有着巨大的力量.不同化的差异化差异化.神经母细胞瘤的神经母细胞瘤这是palbocicliblib.网红酸是什么意思 网红酸是什么意思ribocicliblib 是一个有机物.

更多相关视频

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.7K
Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells12:17

Initiating Differentiation in Immortalized Multipotent Otic Progenitor Cells

Published on: January 2, 2016

8.9K

相关概念视频

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K